PMI Postdoctoral Fellowship Program

Updated: 10 January 2024

What’s our postdoctoral program about?

This is a 2-year fellowship giving you a unique opportunity to work on interdisciplinary and innovative research projects which cover an array of specialties.

Our priority is creating passionate teams of experts from different scientific and technical backgrounds – currently we have over 1,180 scientists, engineers, and technicians working across our sites. With this program, we’ll continue to foster innovation and build our science to the highest standards.

Why join us?

• Our facilities – our R&D Center in Neuchâtel, Switzerland (called ‘the Cube’) is a state-of-the-art research facility, with a great view! Plus, our cutting edge technology, tools, and robust scientific methodologies make us an industry leader.
• Publish your work – you’ll have the opportunity to publish your research in leading peer-reviewed journals.
• Be supported – conduct research with the guidance of a mentor who’s an expert in their field.
• We’re international – you’ll have the opportunity to work with colleagues from all over the world.
• We’re flexible – we truly believe that your work should fit you and not the other way around, which is achieved through our Flexible Work Arrangement Program.
• We’re a certified Top Employer – we consider our employees to be our strongest asset, and we develop talent throughout all levels of the organization.
• We are an equal opportunity employer in an inclusive environment – this is part of our organization's core principles.

If you want to know more about the postdoctoral experience first-hand, find out what our first group of postdocs think.

Interested in applying?

We’re always looking for new talent from different backgrounds, and the next time our postdoctoral program opens for new applications, we'll update this space. Meanwhile, learn more about the career opportunities in product development and research at PMI. 

Our aim at PMI Science

Although smoking rates are declining in many countries, it is estimated that by 2020, the worldwide number of smokers will be around 1 billion. Providing alternative reduced risk products (RRPs) for smokers who would otherwise continue to smoke is our focus at PMI Science. We’re developing novel RRPs that, we believe, will be acceptable to current adult smokers, and with a risk profile that is significantly lower than cigarettes.

In order to assess whether switching to these novel products can reduce the risk of developing the diseases most strongly associated with smoking, when compared to continued smoking, we have developed a comprehensive and extensive scientific assessment program.